Thymosin Beta-4 (10 mg) Dosage Protocol
The full-length 43-amino-acid actin-sequestering peptide (Tβ4) studied for wound healing, tissue repair and cardiac protection — preclinical plus early human wound trials, not FDA-approved.
The major G-actin-sequestering peptide; regulates cell migration and acts as a paracrine repair signal driving angiogenesis, anti-inflammatory and anti-fibrotic effects in preclinical models.
Milligrams, not micrograms: research conventions cite a 2-2.5 mg twice-weekly SC loading phase for 4-6 weeks, then lower maintenance.
Preclinical animal repair data plus early phase-2 human wound trials (pressure/stasis ulcers); not FDA-approved for recovery.
Quickstart Highlights
Thymosin Beta-4 — written Tβ4 or Tβ4 — is a naturally occurring 43-amino-acid peptide (~5 kDa) that is the major G-actin-sequestering protein in mammalian cells, meaning it holds monomeric actin in reserve and regulates how the cell’s cytoskeleton assembles and disassembles[1]. Outside the cell it behaves as a paracrine repair signal, and in preclinical work it has been studied for wound healing, tissue repair, angiogenesis and cardiac protection[1]. In the research-peptide community it is the full-length endogenous molecule most people are actually asking about when they compare it to the popular fragment product “TB-500.”
The honest picture is that Tβ4’s evidence base is largely preclinical (cell-culture and animal models) with a handful of early-phase human trials in dermal wounds and eye disease — it is not an FDA-approved drug for muscle, recovery or anti-aging use. Everything below reflects research conventions and is provided strictly for research and educational reference — not medical advice.
Pre-filled with this protocol’s recommended BAC water and documented starting dose — edit any field to run your own numbers. Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Full reconstitution guide → · Advanced calculator →Mix & measure Thymosin Beta-4 · 10 mg
Supplies Needed
Everything a documented injectable protocol relies on. Nothing here is exotic — sterile technique and accurate measurement matter far more than any single tool.
Protocol Overview
At 5 mg/mL a single 10 mg vial holds 2 mL of usable solution — five 2 mg doses, or roughly two to three weeks of a twice-weekly loading phase from one vial. Because doses are small in volume, an accurate U-100 insulin syringe is the single most important measuring tool.
A common research pattern runs a 4–6 week loading block (around 8–12 doses) followed by spaced maintenance, so a typical research cycle uses two to three 10 mg vials depending on the schedule chosen.
Dosing Protocol
A reference range converted to U-100 units at 5 mg/mL. This is a common research convention, not a titration schedule and not clinical guidance.
| Phase | Dose | Volume (U-100 units / mL) |
|---|---|---|
| Loading (conservative) | 2 mg twice weekly | 40 units (0.40 mL) |
| Loading (upper reference) | 2.5 mg twice weekly | 50 units (0.50 mL) |
| Maintenance | 2 mg every 1–2 weeks | 40 units (0.40 mL) |
| Cycle length | 4–6 week load, then maintain | Not run continuously |
Why Thymosin Beta-4 draws research interest
These are the directions researchers and the peptide community most often explore Thymosin Beta-4 for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.
Wound & tissue repair
Accelerated dermal wound healing in normal, diabetic and aged animal models with increased collagen deposition — the core of its repair interest.
Tβ4 vs 'TB-500'
Tβ4 is the natural 43-amino-acid protein; 'TB-500' is a loosely-used market name usually for a shorter peptide built around Tβ4's actin-binding domain.
Cardiac & angiogenic signaling
Preclinically activates ILK/Akt survival signaling and promotes endothelial migration and new-vessel formation, the basis for the recovery interest.
Evidence ranges from early laboratory work to clinical trials depending on the use — the sections below cover the actual data and sources.
Add 2.0 mL bacteriostatic water to one 10 mg vial → 5 mg/mL (0.5 mg = 10 U-100 units).
Reference loading convention 2–2.5 mg twice weekly; maintenance often drops to 2 mg every 1–2 weeks.
Subcutaneous, 1–2× per week; timing is flexible because Tβ4 is not tied to a workout window.
Preclinical + early human trials — animal repair data plus phase 2 wound trials; not FDA-approved.
Dosing & Reconstitution Guide
Unlike a growth-factor peptide dosed in micrograms, Thymosin Beta-4 is worked with in milligrams and on a twice-weekly rather than daily schedule. Its reported activities — actin sequestration, angiogenesis, anti-inflammatory and anti-fibrotic signaling — are cumulative tissue effects rather than an acute post-exercise pulse, which is why research protocols favor steady, spaced dosing[4].
Standard / Gradual Approach
The reference approach is a loading phase followed by maintenance rather than a slow escalation. A widely cited research convention is 2 to 2.5 mg twice weekly for 4 to 6 weeks, then a maintenance dose of roughly 2 mg every one to two weeks[4]. Reconstituted at 5 mg/mL, a 2 mg dose equals 0.4 mL (40 units on a U-100 syringe) and a 2.5 mg dose equals 0.5 mL (50 units). Because the reported effects are gradual tissue remodeling rather than an acute signal, pushing the dose higher or more often is not obviously more effective and simply increases the amount of an incompletely characterized peptide being administered.
Reconstitution Steps
Reconstitution is standard for a lyophilized peptide. A 2 mL diluent volume dissolves a 10 mg vial cleanly and keeps the milligram-level math simple.
- ▪Sanitize: Swab the vial stopper and the bacteriostatic-water vial with fresh alcohol pads and let them dry.
- ▪Add diluent slowly: Draw 2.0 mL bacteriostatic water and let it run down the inside wall of the vial — do not spray it directly onto the powder.
- ▪Dissolve gently: Swirl; do not shake. The solution should clear within a minute or two.
- ▪Store: Label with the date and refrigerate at 2–8 °C; the reconstituted vial holds ~5 mg/mL.
Storage Instructions
Store the lyophilized vial in the refrigerator or freezer away from light until reconstitution.
After reconstitution, keep the vial refrigerated at 2–8 °C and use within the bacteriostatic-water window (commonly cited as up to ~28 days). Discard if the solution becomes cloudy or discolored.
Important Notes
Practical points that keep a milligram-dosed injectable protocol consistent and honest about what the compound is.
- ▪Tβ4 vs “TB-500”: Full-length Thymosin Beta-4 is the natural 43-amino-acid protein; “TB-500” is a research-market name usually referring to a shorter synthetic peptide built around Tβ4’s actin-binding domain (the heptapeptide LKKTETQ), which reproduces much of the wound-repair activity in animal models[3]. Vendors use the two names loosely, so identity is never guaranteed without a Certificate of Analysis.
- ▪Human evidence is early: Tβ4 has reached only phase 1/2 human trials (pressure ulcers, stasis ulcers, epidermolysis bullosa wounds, dry-eye/corneal disease), where it was reported safe and well tolerated — but it has not completed pivotal trials and is not approved[4].
- ▪Recovery and cardiac claims are extrapolated: The cardiac-protection and satellite-cell interest comes from rodent and cell studies[2]; there is no controlled human trial showing Tβ4 improves athletic injury recovery.
- ▪Growth-signaling caution: Because Tβ4 promotes angiogenesis and cell migration, there is a theoretical concern about supporting the growth of pre-existing abnormal tissue; anyone with a personal or family cancer history should treat that as a hard stop.
- ▪Unverified purity: Grey-market Tβ4 is a peptide easily degraded or mislabeled; without a COA, identity and potency cannot be assumed.
How This Works
Inside cells, Thymosin Beta-4 binds monomeric (G-)actin and stabilizes it, making it the principal actin-sequestering peptide of the cell[1]. By buffering the pool of free actin, it helps govern the rapid cytoskeletal remodeling that underlies cell movement — and cell migration is central to wound closure, new blood-vessel formation and tissue repair.
Outside the cell, Tβ4 acts as a paracrine signal. In cardiac work it was shown to form a complex with PINCH and integrin-linked kinase (ILK), activating the survival kinase Akt; after coronary-artery ligation in mice this improved cardiomyocyte survival and cardiac function[2]. In skin it accelerated dermal wound repair in normal, diabetic (db/db) and aged animals, with much of the activity traced to its short actin-binding domain[3]. The leap from these models to proven human recovery benefit is exactly the gap the honest reader should keep in mind.
Lifestyle Factors
Because Tβ4 is a repair-signaling peptide rather than an anabolic driver, whatever tissue support it might offer still rests on the fundamentals of healing — adequate protein, sleep, sensible training loads and time. It does not replace rehabilitation for a real injury.
Given the angiogenic and pro-migration activity, research users generally treat routine health screening and a clear personal/family cancer history as prerequisites rather than afterthoughts, and avoid stacking multiple poorly characterized growth signals at once.
Potential Benefits & Side Effects
What the preclinical and early-clinical literature reports; most of this is animal and cell evidence plus small early-phase human wound trials, not a supervised approved therapy, so individual outcomes are unknown.
Reported Effects
- ▪Dermal wound repair: Accelerated healing of full-thickness skin wounds in normal, diabetic and aged animal models, with increased collagen deposition and wound contraction[3].
- ▪Angiogenesis and cell migration: Promotes endothelial cell migration and new-vessel formation, the mechanistic basis for its tissue-repair interest[1].
- ▪Cardiac cell survival (preclinical): Improved cardiomyocyte survival and heart function after induced injury in mice via ILK/Akt signaling[2].
- ▪Early human wound signals: In phase 2 trials, topical/injected Tβ4 was reported to accelerate repair of pressure ulcers, stasis ulcers and epidermolysis bullosa wounds, and was well tolerated[4].
- ▪Studied for recovery: The community interest is soft-tissue and tendon/muscle recovery — a plausible extrapolation from the repair pharmacology that has not been confirmed in controlled human athletic-injury studies.
Common Side Effects
- ▪Injection-site reactions: Local redness, soreness or swelling are common to any subcutaneous injection.
- ▪Fatigue / head-flush reports: Anecdotal reports of transient tiredness or flushing exist in the research-user community; these are not well characterized in controlled data.
- ▪Theoretical proliferative concern: As a pro-angiogenic, pro-migration signal, Tβ4 activity raises a theoretical concern about promoting growth of pre-existing abnormal cells — a genuine reason for caution.
- ▪Unknown long-term safety: There is no long-term human safety database for the grey-market peptide; effects of repeated cycles are simply not characterized.
Injection Technique
Subcutaneous injection technique is standard. Accurate measurement and site rotation matter more than speed.
Pre-Injection Preparation
- ▪Wash hands; let the refrigerated vial come toward room temperature to reduce sting.
- ▪Swab the stopper and injection site; let the alcohol dry fully.
- ▪Draw your dose into a fresh U-100 syringe and tap out air bubbles — confirm the unit mark before injecting.
Injection Procedure
- ▪Pinch a subcutaneous skinfold (abdomen is typical) and insert at 45–90°.
- ▪Inject at a steady, even pace.
- ▪Withdraw and apply light pressure with a clean swab — do not rub.
Post-Injection Care
- ▪Drop the used syringe straight into a puncture-proof sharps container.
- ▪Rotate injection sites between doses to avoid local irritation.
- ▪Return the vial to the refrigerator promptly and track your dose dates.
Recommended Source
For high-purity research peptides, we point researchers to Prime Lab Peptides for Thymosin Beta-4 (10 mg Vial).
Why Prime Lab Peptides?
- ▪Top-rated on Trustpilot: Independently reviewed as the highest-rated peptide lab on Trustpilot — making it the best current source in the USA.
- ▪Third-party tested: Every batch ships with a Certificate of Analysis (COA) confirming purity and composition.
- ▪Consistent quality: ISO-aligned manufacturing and handling keep product integrity reliable batch to batch.
- ▪Cold-chain integrity: Temperature-controlled shipping and storage across the whole fulfilment chain.
- ▪Research-grade purity: Fit for educational and research use that demands high-quality peptides.
Note: Product availability and specifications subject to change. Verify current product details on supplier website.
References
- 1
Cell Motil Cytoskeleton — The beta-thymosins: intracellular and extracellular activities of a versatile actin binding protein family (Mannherz & Hannappel, 2009)Review establishing thymosin beta-4 as a ~5 kDa, ~40-44 amino-acid, N-terminally acetylated peptide that is the main intracellular G-actin-sequestering factor, with paracrine effects reported in cardiac protection, angiogenesis, wound healing and hair growth. PMID 19405116. DOI 10.1002/cm.20371.
- 2
Nature — Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair (Bock-Marquette et al., 2004)Shows Tβ4 forms a complex with PINCH and ILK to activate Akt, enhancing cardiomyocyte survival and improving cardiac function after coronary-artery ligation in mice. PMID 15565145. DOI 10.1038/nature03000.
- 3
Wound Repair Regen — Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic and aged mice (Philp et al., 2003)Demonstrates Tβ4 accelerates full-thickness dermal wound repair in diabetic and aged animals, and that its seven-amino-acid actin-binding domain (LKKTETQ) reproduces much of the activity — the honest basis for the Tβ4-versus-‘TB-500-fragment’ distinction. PMID 12581423. DOI 10.1046/j.1524-475x.2003.11105.x.
- 4
Vitamins and Hormones — Thymosin β4 Promotes Dermal Healing (Kleinman & Sosne, 2016)Review summarizing Tβ4’s angiogenic, anti-inflammatory and regenerative activity across preclinical wound models and phase 2 human trials in pressure ulcers, stasis ulcers and epidermolysis bullosa wounds, where it was safe and well tolerated. PMID 27450738. DOI 10.1016/bs.vh.2016.04.005.
- 5
Expert Opin Biol Ther — The role of thymosin-β4 in kidney disease (Vasilopoulou et al., 2015)Describes thymosin-β4 as the major G-actin-sequestering protein and a regulator of inflammation and fibrosis that was, at the time, already being tested in clinical trials for heart disease and wound healing. PMID 26096077. DOI 10.1517/14712598.2015.1009891.
Thymosin Beta-4 — frequently asked questions
How do I reconstitute a 10 mg vial of Thymosin Beta-4?
Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units.
How much bacteriostatic water should I add to Thymosin Beta-4?
There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units.
What do the "units" on an insulin syringe mean?
On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand.
How should I store Thymosin Beta-4 after mixing?
Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product.
How many doses does a 10 mg vial of Thymosin Beta-4 provide?
Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose.
Is Thymosin Beta-4 approved for human use?
No. Thymosin Beta-4 is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.
New protocols & dosing updates
Reconstitution charts, new peptide protocols and safety updates — straight to your inbox. No spam, unsubscribe anytime.